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Abstract
Background: The coronary slow flow (CSF) phenomenon is a delayed antegrade progression 
of contrast agent to the distal branch of a coronary artery in the absence of obstructive coronary 
artery disease (CAD). A narrow fragmented QRS (fQRS) has been reported as a significant 
predictor of sudden cardiac death in patients with idiopathic dilated cardiomyopathy. The 
present study aimed to investigate the relationship between a narrow fQRS on the admission 
electrocardiogram (ECG) and CSF on coronary angiography.
Methods: This study included 165 consecutive patients (112 CSF, 53 controls) who under-
went first-time diagnostic conventional coronary angiography for suspected CAD. Coronary 
flow was quantified by thrombolysis in myocardial infarction (TIMI) frame count (TFC). The 
patients were divided into two groups according to the presence or absence of a narrow fQRS 
complex on the admission ECG.
Results: Forty four patients were in the fQRS group (mean age, 52.97 ± 3.13 years). There 
was no difference between the two groups with respect to age, gender, body mass index, family 
history, hyperlipidemia, hypertension, or diabetes mellitus. The extent of CSF was significantly 
greater in the fQRS group compared to the non-fragmented group (p < 0.001). A significant 
correlation was also found between mean TFC values and fQRS (p < 0.001). On multivariate 
analysis, only CSF (p = 0.03) was a significant independent predictor for narrow fQRS, after 
adjustment for other parameters.
Conclusions: The narrow fQRS is a simple, inexpensive, and readily available noninvasive 
ECG parameter that may be a new potential indicator of myocardial damage in patients with 
CSF. (Cardiol J 2015; 22, 4: 428–436)
Key words: coronary slow flow, narrow fragmented QRS, thrombolysis in  
myocardial infarction frame count, electrocardiography
Introduction
The coronary slow flow (CSF) phenomenon is 
an angiographic finding characterized by a delayed 
antegrade progression of contrast agent to the 
distal branch of a coronary artery in the absence 
of obstructive epicardial coronary artery disease 
(CAD), coronary ectasia, coronary vasospasm, or 
acute coronary syndrome [1]. It is not a rare an-
giographic finding, having a reported incidence of 
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1–7% in patients undergoing coronary angiography 
for suspected CAD [2]. Although neither the exact 
etiologies nor the pathophysiological mechanisms 
are yet fully understood, several potential mecha-
nisms have been proposed, including microvascular 
and endothelial dysfunction, small-vessel disease, 
diffuse atherosclerosis, increased platelet aggrega-
bility, and inflammation [3–7]. CSF has been linked 
to various clinical manifestations, such as hyper-
tension, stable and unstable angina pectoris, acute 
myocardial infarction, life-threatening arrhythmias, 
and sudden cardiac death [8].
Fragmented QRS (fQRS), which has attracted 
great interest as a new, easy to assess, and reliable 
electrocardiographic (ECG) finding in clinical prac-
tice, has been defined as the presence of notched 
R or S waves without accompanying typical bundle 
branch block, or the existence of an additional 
wave resembling an RSR’ pattern in the original 
QRS complex (with a duration of < 120 ms) [9]. 
It reflects impaired ventricular depolarization due 
to heterogeneous electrical activation of ischemic 
and/or infarcted ventricular myocardium. A narrow 
fQRS, caused by non-specific electrical deviation 
and/or deformation of QRS morphology, has re-
cently been associated with a high risk of sudden 
cardiac death in patients with idiopathic dilated 
cardiomyopathy [10]. Furthermore, a wide or nar-
row fQRS on the admission ECG strongly predicts 
event-free survival rates in patients with dilated 
cardiomyopathy and a left ventricular ejection frac-
tion (LVEF) < 40% [11].
Since there is no information in the literature 
concerning the relationship between the presence 
of a narrow fQRS on the admission ECG and the 
occurrence and extent of CSF on coronary angio-
graphy, we aimed to investigate this association in 
the present study.
Methods
Patient selection and study protocol
This is a cross-sectional observational study. 
Coronary angiography was performed on 5,856 
consecutive patients between July 2010 and Oc-
tober 2014, and 165 (2.8%) patients who had 
angiographically proven normal coronary arteries 
and slow coronary flow were included in the study. 
During this period, of 482 (8.2%) patients who had 
normal coronary arteries and normal coronary flow, 
53 were randomly enrolled as the control group 
by 3 different experienced cardiologists without 
knowledge of the patients’ demographic, clinical 
and laboratory data. All patients had angiographi-
cally normal coronary arteries, with varying coro-
nary flow rates and without any atherosclerotic 
lesion. Study participants were divided into two 
groups according to their coronary flow rates: 
112 patients with isolated CSF and 53 control 
subjects with normal coronary flow.
All study patients had typical chest pain or 
angina-equivalent symptoms with positive results 
from either a treadmill test or a myocardial perfu-
sion study. Demographic, clinical, and laboratory 
characteristics of the study groups, which were 
taken from each patient’s history and physical 
examination, were recorded by systematic review 
of the patient files. In addition, the angiographic 
characteristics of the patient groups were obtained 
from the database of the cardiac catheterization 
laboratory.
The exclusion criteria for the present study 
were as follows: acute coronary syndrome, coro-
nary vasospasm, coronary ectasia or anomaly, sys-
tolic (LVEF < 50%) and/or diastolic heart failure, 
moderate to severe heart valve disease, QRSd 
> 120 ms on the 12-lead admission ECG, acute or 
chronic renal disease (creatinine-based estimated 
glomerular filtration rate [GFR] calculated by the 
Cockcroft–Gault formula < 90 mL/min/1.73 m2, 
serum creatinine > 1.4 mg/dL), obstructive CAD, 
and non-coronary atherosclerosis, including stroke, 
peripheral arterial disease, carotid artery disease, 
hematological disorders, chronic obstructive lung 
disease, impaired liver function (aspartate ami-
notransferase/alanine aminotransferase elevation 
to > 3 times the upper limit of normal), evidence of 
ongoing infection or inflammation, endocrine disor-
ders such as metabolic syndrome, medications that 
affect coagulation pathways, known malignancy, 
autoimmune diseases, major trauma or surgery in 
previous 3 months, thyroid dysfunctions such as 
hypothyroidism and hyperthyroidism, inadequate 
electrocardiographic or echocardiographic images, 
and presence of bundle branch block, Wolff–Parkin-
son–White syndrome, Brugada syndrome, or paced 
rhythm. Any of the study participants who were 
taking vasoactive drugs underwent a 3-day “wash-
out” before the coronary angiography procedure.
All study participants underwent a transtho-
racic echocardiographic examination using a Vivid 
S6 device with a 3.5 MHz phased array transducer 
(GE Medical Systems, Horten, Norway) to evaluate 
left ventricular morphology and function. Record-
ings were performed with the patients in the left 
lateral decubitus position. The LVEF was measured 
using the modified Simpson’s rule, according to the 
most recent guidelines [12].
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Written informed consent was obtained from 
all the participants and the study was approved 
by the local Ethics Committee and institutional 
Review Board. The study protocol complied with 
the Declaration of Helsinki.
Definitions
Smoking was defined as the current regular 
use of cigarettes. Hypertension was diagnosed if 
systolic arterial pressure exceeded 140 mm Hg 
and/or diastolic arterial pressure exceeded 
90 mm Hg, or if the patient was taking antihyperten-
sive drugs [13]. Hyperlipidemia was defined as fast-
ing total serum cholesterol > 200 mg/dL, low-den-
sity lipoprotein cholesterol (LDL-C) > 130 mg/dL, 
serum triglycerides (TG) > 180 mg/dL, or use 
of lipid-lowering drugs because of a history of 
hypercholesterolemia [14]. Diabetes mellitus was 
defined as a previous history of the disease, use of 
diet, insulin or oral antidiabetic drugs, or a fasting 
venous blood glucose level ≥ 126 mg/dL on 2 oc-
casions in previously untreated patients [15]. GFR 
for each patient was calculated using the measured 
plasma creatinine levels and the Cockcroft-Gault 
formula for the estimation of renal function [16]. 
The height and weight of the study participants 
were measured, and body mass index (BMI) was 
calculated as body weight in kilograms divided by 
the square of the height in meters (kg/m2).
Data analysis
A 12-lead ECG was obtained from all patients 
(filter range 0.5 Hz to 150 Hz, AC filter 60 Hz, 
25 mm/s, 10 mm/mV). A narrow fQRS was described 
as a narrow QRS complex (duration < 120 ms) 
in addition to notching in the R’ or QRS complex. 
For the diagnosis of fQRS, the presence of various 
RSR’ patterns, including an additional R wave (R’), 
or notching of the R wave or S wave, or the pres-
ence of more than one R’ (fragmentation), without 
typical bundle branch block, was sought in two 
contiguous leads corresponding to a major lead set 
for major coronary artery territory. A notch on an 
R or S wave was defined as a definite but transient 
reversal of direction of the main deflection (Fig. 1) 
[4, 9]. All ECGs were analyzed without using any 
magnification by 2 independent clinicians who were 
blinded to the study design and to the clinical and 
angiographic data. The inter-observer concordance 
rate in the detection of fQRS was 97%. In case of 
disagreement, the final diagnosis was arrived at 
by mutual agreement. The intra-observer con-
cordance rate was 98%. The QRS duration was 
determined by measuring the longest QRS in any 
lead, both by manual reading and from the digital 
records obtained by the ECG machine.
Coronary angiography procedure  
and determination of CSF
Coronary angiography was performed via 
femoral approach using the standard Judkins tech-
nique with a monoplane cineangiography system. 
Coronary angiograms were recorded in right and 
left oblique planes using cranial and caudal angu-
lations, at a rate of 30 Fr/s. During the coronary 
angiography procedures, iopromide (Ultravist 370, 
Schering AG, Berlin, Germany) was used as a con-
trast agent in all study participants. The patients 
were evaluated for the presence of CSF during 
coronary angiography. Coronary blood flow rates 
were measured quantitatively, using the throm-
bolysis in myocardial infarction (TIMI) frame count 
method (TFC), by 2 experienced interventional 
cardiologists who were totally blinded to the study 
[17]. The intra- and inter-observer coefficients of 
variation were 4.9% and 7.4%, respectively.
In this method, the number of cine frames 
required for the contrast to reach standard distal 
coronary landmarks in the left anterior descending 
(LAD), left circumflex (LCX), and right coronary 
(RCA) arteries is noted. Initial frame count is 
defined as the frame in which concentrated dye 
occupies the full width of the proximal coronary 
artery lumen, touching both borders of the lumen, 
Figure 1. Different examples of an fragmented QRS complex and 12-lead electrocardiogram [9].
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and having forward motion distal to the artery. The 
final frame is designated when the leading edge of 
the contrast column first reaches the distal end. 
Predefined distal landmarks are the distal bifurca-
tion for the LAD, commonly referred to as the 
“moustache”, “pitchfork” or “whale’s tail”, the 
distal bifurcation of the segment with the longest 
total distance for the LCX, and the first branch of 
the posterolateral artery for the RCA. Since the 
LAD artery is usually longer than the other major 
coronary arteries, the TFC for this vessel is often 
higher. To obtain the corrected TFC for the LAD, 
TFC was divided by 1.7 [17]. The mean TFC for 
each patient and control individual was calculated 
by totaling the TFC for the LAD, LCX, and RCA and 
then dividing by 3. The standard corrected mean 
values for normal visualization of the coronary 
arteries are 36.2 ± 2.6 Fr for the LAD, 22.2 ± 4.1 Fr 
for the LCX, and 20.4 ± 3 Fr for the RCA [17]. 
The standard corrected mean value for the LAD 
coronary artery is 21.1 ± 1.5 Fr. All study par-
ticipants with a TFC that exceeded the previously 
published range for the particular vessel by more 
than 2 standard deviations (SDs) were considered 
to have CSF. In our study, values obtained above 
these thresholds in any of the 3 coronary arteries 
(not all 3) were considered to be CSF.
Statistical analysis
Continuous, normally distributed variables 
were expressed as mean ± SD and non-normally 
distributed variables as median (interquartile 
range). Categorical variables were expressed as 
frequencies and/or percentages. The Kolmogorov– 
–Smirnov test was used to evaluate whether the 
continuous variables were normally distributed. 
Student’s t-test was used for the comparison 
of normally distributed continuous numerical 
variables, the Mann–Whitney U-test was used for 
non-normally distributed numerical variables, and 
the c2-test was used for comparing categorical vari-
ables between the two groups. Any correlation be-
tween the data was tested by Spearman or Pearson 
correlation analysis. A univariate and backward 
stepwise multivariate Cox regression analysis, 
which included variables with a p-value less than 
0.1, were performed to identify independent pre-
dictors of a narrow fQRS. A 2-sided p-value was 
considered for all comparisons. Statistical signifi-
cance was defined as p < 0.05. Statistical analyses 
were carried out using the Statistical Package 
for Social Sciences for Windows 13.0 (SPSS Inc., 
Chicago, Illinois, USA).
Results
The baseline demographic, clinical and labo-
ratory characteristics of the CSF and the control 
group are presented in Table 1. There were no 
statistically significant differences between the 
two groups in terms of age, male gender, hyperten-
sion, diabetes, hyperlipidemia, cigarette smoking, 
or family history, hematocrit, hemoglobin, white 
blood cell count (WBC), or total cholesterol (all 
p > 0.05). However, BMI (p < 0.001), systolic and 
diastolic blood pressure (p = 0.001 and p = 0.008, 
respectively), heart rate (p = 0.001), and the 
incidence of a narrow fQRS complex (p = 0.007), 
creatinine (p < 0.001), fasting glucose (p < 0.001), 
LDL-C (p < 0.001), and TG (p = 0.001) were 
significantly higher in the CSF group compared to 
the control group. Moreover, LVEF (p = 0.001), 
GFR (p < 0.001), and high-density lipoprotein 
cholesterol (p < 0.001) were significantly lower 
in the CSF group compared to the controls. There 
were no significant differences between the two 
groups with respect to the use of medications (all 
p > 0.05).
The baseline demographic, clinical and labo-
ratory characteristics of the fragmented and non-
fragmented QRS groups are presented in Table 2. 
There was no difference between two groups 
except diastolic blood pressure (p = 0.02) and 
hematocrit levels (p = 0.03), which were found 
to be increased in the fragmented QRS groups as 
compared to the non-fragmented QRS groups.
Those patients who were deemed to have CSF 
had slower coronary blood flow by TFC measure-
ments when compared with the control group. 
Twenty-two (19.6%) patients had slow flow in all 
3 vessels, 36 (32.1%) patients in 2 vessels, and 
54 (48.2%) patients in 1 vessel. The distribution of 
CSF according to the coronary vessels was as fol-
lows: 70 (63%) patients had slow flow in the LAD, 
57 (51%) had slow flow in the LCX, and 68 (61%) 
had slow flow in the RCA. All TFC values for the 
LAD, LCX, and RCA vessels, as well as the mean 
TFC, were found to be significantly higher in the 
CSF group than in the controls (all p < 0.001).
In the fQRS(+) group, 17 (38.6%) patients 
had slow flow in all 3 vessels, 12 (27.2%) patients 
in 2 vessels, and 8 (18.1%) patients in 1 vessel. 
In the fQRS(–) group, 5 (4.1%) patients had 
slow flow in all 3 vessels, 24 (19.8%) patients in 
2 vessels, and 46 (38%) patients in 1 vessel. The 
extent of CSF was significantly greater in the 
fQRS(+) group compared to the non-fQRS group 
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(p < 0.001). The distribution of CSF according to 
the coronary vessels in the fQRS(+) group was as 
follows: 33 (75%) patients had slow flow in the LAD, 
24 (54.5%) had slow flow in the LCX, and 26 (59%) 
had slow flow in the RCA. Furthermore, those pa-
tients who were deemed to have narrow fQRS com-
plex also had slower coronary blood flow by TFC 
measurements when compared with the non-fQRS 
group. All TFC values for the LAD (p < 0.001), 
LCX (p = 0.003), and RCA (p = 0.023), as well as 
the mean TFC (p < 0.001), were found to be sig-
nificantly higher in the narrow fragmented group 
than in the non-fragmented group (Table 3).
When the correlations between fQRS and 
baseline demographic, clinical and laboratory 
parameters were assessed, fQRS was found to be 
significantly negatively correlated with diastolic 
blood pressure (p = 0.008). Furthermore, there 
was a positive correlation between the presence 
of fQRS on the admission ECG and the blood flow 
in all 3 coronary vessels (p < 0.001, p = 0.003, 
p = 0.016, respectively, for TFC in the LAD, LCX, 
and RCA). The TFC of the LAD showed the strong-
est correlation with fQRS (r = 0.416, p < 0.001). 
A strong significant relationship was also seen be-
tween the mean TFC values and fQRS (r = 0.383, 
Table 1. Baseline demographic and clinical characteristics of the coronary slow flow (CSF) patients and 
the control group (NCF).
CSF (n = 112) NCF (n = 53) P
Age [years] 53.33 ± 3.0 53.67 ± 2.88 0.493
Gender, male 73 (65.1%) 27 (50.9%) 0.81
Body mass index [kg/m2] 28.18 ± 1.14 27.12 ± 0.67 < 0.001
Family history 34 (30.3%) 9 (16.9%) 0.68
Smoking 31 (27.6%) 23 (43.3%) 0.70
Diabetes mellitus 23 (20.5%) 10 (18.8%) 0.80
Hypertension 63 (56.2%) 23 (43.3%) 0.12
Hyperlipidemia 46 (41%) 20 (37.7%) 0.68
Systolic BP [mm Hg] 131.49 ± 5.54 124.77 ± 7.38 0.001
Diastolic BP [mm Hg] 72.41 ± 4.32 70.56 ± 3.73 0.008
Heart rate [min] 76.08 ± 5.33 73.35 ± 3.99 0.001
Ejection fraction [%] 59.10 ± 4.11 61.33 ± 3.05 0.001
fQRS 37 (33%) 7 (13.2%) 0.007
GFR [mL/min/1.73 m2] 109.14 ± 9.26 127.64 ± 7.37 < 0.001
Total cholesterol [mg/dL] 192.57 ± 36.62 191.15 ± 33.33 0.811
LDL-cholesterol [mg/dL] 148.36 ± 23.36 121.77 ± 16.31 < 0.001
HDL-cholesterol [mg/dL] 39.33 ± 5.68 44.62 ± 9.86 0.001
Triglyceride [mg/dL] 177.96 ± 44.07 154.77 ± 37.51 0.001
Fasting glucose [mg/dL] 112.07 ± 26.35 95.32 ± 13.33 < 0.001
Creatinine [mg/dL] 0.85 ± 0.16 0.73 ± 0.13 < 0.001
Hemoglobin [g/dL] 12.86 ± 1.85 12.64 ± 1.16 0.428
Hematocrit [%] 41.6 ± 2.36 40.9 ± 2.14 0.06
WBC [103/mm3] 7.67 ± 1.39 7.48 ± 1.25 0.402
Acetylsalicylic acid 25 (22.3%) 10 (18.8%) 0.62
Beta-blocker 14 (12.5%) 7 (13.2%) 0.90
Ca channel blocker 15 (13.3%) 7 (13.2%) 0.97
Nitrate 18 (16%) 7 (13.2%) 0.63
ACEI/ARB 23 (20.5%) 8 (15.0%) 0.40
Statin 19 (16.9%) 7 (13.2%) 0.71
Values are presented as mean ± standard deviation or number (%), as appropriate; ACEI — angiotensin-converting enzyme inhibitor; ARB — 
angiotensin receptor blocker; BP — blood pressure; fQRS — fragmented QRS complex; GFR — glomerular filtration rate; HDL — high-density 
lipoprotein; LDL — low-density lipoprotein; SBP — systolic blood pressure; WBC — white blood cell count
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p < 0.001). There was no correlation between fQRS 
and other parameters (Table 4).
On multivariate analysis, only CSF (OR 2.66, 
95% CI 1.075–6.62, p = 0.03) was found to be 
Table 3. Comparison of angiographic characteristics between the fragmented QRS (+) and the  
non-fragmented QRS (–) groups.
TIMI frame count  
measurements
Fragmented QRS (+)  
(n = 44)
Non-fragmented QRS (–)  
(n = 121)
P
Mean 36.93 ± 12.26 27.86 ± 8.63 < 0.001
Left anterior descending artery 
(corrected)
38.97 ± 12.89 27.97 ± 9.81 < 0.001
Left circumflex artery 34.54 ± 12.89 27.71 ± 12.62 0.003
Right coronary artery 33.88 ± 14.83 27.96 ± 13.40 0.023
Table 2. Baseline demographic and clinical characteristics of the fragmented QRS (+) and the  
non-fragmented QRS (–) groups.
Fragmented QRS (+)  
(n = 44)
Non-fragmented QRS (–)  
(n = 121)
P
Age [years] 52.97 ± 3.13 53.61 ± 2.89 0.22
Gender, male 31 (70.4%) 69 (57%) 0.11
BMI [kg/m2] 28.06 ± 1.28 27.76 ± 1.06 0.13
Family history 9 (20.4%) 34 (28%) 0.32
Smoking 13 (29.5%) 31 (25.6%) 0.61
Diabetes mellitus 9 (20.4%) 24 (19.8%) 0.93
Hypertension 24 (54.5%) 62 (51.2%) 0.70
Hyperlipidemia 16 (36.3%) 50 (41.3%) 0.56
Systolic BP [mm Hg] 130.15 ± 6.97 129.03 ± 6.91 0.35
Diastolic BP [mm Hg] 73.25 ± 4.90 71.30 ± 3.83 0.02
Heart rate [min] 75.31 ± 5.23 75.17 ± 5.23 0.86
Ejection fraction [%] 59.70 ± 4.03 59.86 ± 3.91 0.81
GFR [mL/min/1.73 m2] 113.56 ± 11.30 115.63 ± 12.59 0.31
Total cholesterol [mg/dL] 189.84 ± 35.11 192.94 ± 35.76 0.61
LDL-cholesterol [mg/dL] 139.68 ± 20.44 139.87 ± 26.12 0.96
HDL-cholesterol [mg/dL] 39.63 ± 5.31 41.53 ± 8.33 0.08
Triglyceride [mg/dL] 163.43 ± 38.62 173.09 ± 44.81  0.17
Fasting glucose [mg/dL] 108.04 ± 20.79 106.19 ± 25.45 0.63
Creatinine [mg/dL] 0.81 ± 0.16 0,81 ± 0,17 0.89
Hemoglobin [g/dL] 12.79 ± 2.09 12.79 ± 1.48 0.98
Hematocrit [%] 41.9 ± 2.07 41.1 ± 2.3 0.03
WBC [103/mm3] 7.43 ± 1.46 7.67 ± 1.31 0.33
Acetylsalicylic acid 8 (18.1%) 27 (22.3%) 0.56
Beta-blocker 5 (11.3%) 16 (13.2%) 0.75
Ca channel blocker 8 (18.1%) 14 (11.5%) 0.26
Nitrate 8 (18.1%) 17 (14.0%) 0.51
ACEI/ARB 11 (25.0%) 20 (16.5%) 0.21
Statin 10 (22.7%) 16 (13.2%) 0.13
Abbreviations as in Table 1
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Table 4. Correlation analysis between the fQRS 
complex and clinical, laboratory and angio-
graphic parameters of CSF patients.
Variables r p
Age –0.096 0.220
BMI 0.117 0.134
SBP 0.072 0.357
DBP 0.204 0.008
Heart rate –0.047 0.549
Ejection fraction –0.018 0.815
Mean TFC 0.383 < 0.001
LAD TFC (corrected) 0.416 < 0.001
LCX TFC 0.233 0.003
RCA TFC 0.188 0.016
TC –0.039 0.621
LDL-C –0.003 0.965
HDL-C –0.110 0.160
Triglyceride –0.099 0.207
Glucose 0.034 0.667
Creatinine 0.010 0.894
GFR –0.075 0.340
BMI — body mass index; SBP — systolic blood pressure; DBP — 
diastolic blood pressure; TFC — TIMI frame count; LAD — left an-
terior descending artery; LCX — left circumflex artery; RCA — right 
coronary artery; TC — total cholesterol; LDL-C — low-density lipo-
protein cholesterol; HDL-C — high-density lipoprotein cholesterol; 
GFR — glomerular filtration rate
significant predictors, such as age, male gender, 
systolic and diastolic blood pressure, hyperten-
sion, diabetes, hyperlipidemia, smoking, family 
history, heart rate, LVEF, GFR, BMI, WBC, and 
hemoglobin (Table 5).
Discussion
The present study demonstrated a significant 
relation between the presence of a narrow fQRS 
complex on the admission ECG and CSF confirmed 
by coronary angiography. Moreover, we found 
a significant positive association between narrow 
fQRS and the extent and severity of CSF. On 
multivariate analysis, only CSF was found to be 
a significant independent predictor of a narrow 
fQRS, after adjustment for other risk parameters. 
To the best of our knowledge, this is the first study 
to demonstrate a correlation between the presence 
of a narrow fQRS complex on the admission ECG 
and the presence of CSF. In addition, a strong re-
lation between a narrow fQRS and the extent and 
severity of CSF is reported for the first time.
Although the precise etiology and underlying 
pathophysiological mechanisms of CSF have not 
been consistently determined, it is a well known 
angiographic finding, whose incidence has been 
reported as 1–7% in patients undergoing coronary 
angiography for suspected CAD. CSF has been dem-
onstrated to be more common in males, smokers, 
and in individuals with hyperlipidemia, metabolic 
syndrome, or obesity [18]. However, we were unable 
Table 5. Univariate and multivariate logistic regression analyses for predictors of a narrow fragmented 
QRS.
Univariate Multivariate
OR (95% CI) P OR (95% CI) P
Age 0.929 (0.82–1.04) 0.219
Coronary slow flow 3.24 (1.33–7.87) 0.009 2.66 (1.07–6.62) 0.034
Male gender 1.79 (0.85–3.77) 0.121 0.67 (0.33–1.45) 0.331
Diastolic BP 1.11 (1.02–1.20) 0.01 1.08 (1.0–1.18) 0.051
Hypertension 1.14 (0.57–2.28) 0.70
Smoking status 1.21 (0.56–2.61) 0.61
Hyperlipidemia 0.81 (0.39–1.65) 0.56
Diabetes mellitus 1.03 (0.44–2.45) 0.93
GFR 0.98 (0.95–1.01) 0.33
Ejection fraction 0.98 (0.90–1.08) 0.81
Systolic BP 1.03 (0.97–1.07) 0.35
White blood cell count 0.87 (0.66–1.13) 0.30
Hemoglobin 0.99 (0.81–1.22) 0.98
OR — odds ratio; CI — confidence interval; GFR — glomerular filtration rate; BP — blood pressure 
a significant independent predictor for a narrow 
fQRS complex, after adjustment for other param-
eters that univariate analysis had identified as 
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to show any difference between the CSF and control 
groups in terms of age, gender, or other risk factors 
for CAD, including hypertension, diabetes, dyslipi-
demia, family history, and smoking; the exception 
was BMI, which was found to be higher in patients 
with CSF, consistently with some other previous 
studies [19, 20]. Several important mechanisms 
have been proposed for the development of CSF, in-
cluding endothelial dysfunction, diffuse atheroscle-
rosis, microvascular vasomotor dysfunction, small-
vessel disease, imbalance of vasoactive substances, 
and raised platelet aggregability [3–6]. Inflammation 
has also been reported to play an important role 
in the development of CSF [7]. Furthermore, not 
only microvascular dysfunction, but also epicardial 
CAD was demonstrated by intravascular ultrasound 
studies to be an important pathophysiological fac-
tor for CSF [21]. Oxidative agents and free radical 
damage may also play a role in the pathogenesis of 
CSF. Hypertension, stable and unstable angina pec-
toris, acute myocardial infarction, life-threatening 
arrhythmias, and sudden cardiac death are among 
the main clinical sequelae of CSF [9].
The fQRS is a simple, inexpensive, and readily 
available noninvasive ECG parameter that can be 
easily identified by clinicians. It may occur because 
of the heterogeneous activation of ischemic or in-
farcted ventricles during ischemic or inflammatory 
heart disease. Scar or fibrotic tissue, resulting from 
cardiac remodeling after ischemic heart disease 
or cardiomyopathy, can lead to hemodynamically 
significant arrhythmias and congestive heart fail-
ure, and eventually to cardiovascular death. The 
presence of fQRS has been demonstrated to be 
an independent predictor of impaired myocardial 
perfusion and left ventricular function detected 
by myocardial single-photon emission computed 
tomography imaging in patients with ischemic 
heart disease [9, 22, 23]. Moreover, fQRS, which 
may be widened or narrowed, has been reported to 
be related with a high incidence of major adverse 
cardiovascular events, including mortality due to 
hemodynamically significant ventricular arrhyth-
mic events in CAD, acute coronary syndromes 
[24, 25], hypertrophic obstructive cardiomyopathy 
[26], ischemic and non-ischemic cardiomyopathy 
[27, 28], and decompensated systolic heart failure 
[29]. Moreover, a significant relation between the 
presence of wide fQRS and the occurrence of CSF 
was demonstrated by Yilmaz et al. [30]. The fQRS 
was found to be significantly higher in patients with 
CSF compared to the control group. However, the 
investigators did not demonstrate any association 
between the fQRS and the extent and severity 
of CSF. In our study, for the first time, we report 
a significant relation between the presence of 
a narrow fQRS complex on the admission ECG 
and the occurrence of CSF, confirmed by coronary 
angio graphy. In contrast to the study by Yilmaz 
et al. [30], we demonstrated a strong association 
between a narrow fQRS and the extent and sever-
ity of CSF. The TFCs of all 3 coronary artery were 
found to be significantly positively related with the 
presence of a narrow fQRS. It seems that the pres-
ence of a narrow fQRS is affected by the degree 
of flow rate in the coronary arteries. Moreover, in 
our study, similarly to Yilmaz et al. [30], we found 
that only CSF was an independent predictor for 
fQRS on multivariate analysis, after adjustment for 
other parameters. Although the main underlying 
pathophysiological mechanisms linking a narrow 
fQRS and CSF were not elucidated in previous 
studies, cardiac arrhythmias and conduction distur-
bances, including fQRS, may be due to myocardial 
inflammation, myocardial ischemia or scar, which 
may lead to depolarization abnormalities of the 
myocardium at the cellular level.
Limitations of the study
The present study had some limitations. First, 
the study population was relatively small; however, 
we were still able to demonstrate an important 
association between the presence of a narrow 
fQRS on the admission ECG and the occurrence 
of CSF on coronary angiography. Second, since 
the patients did not undergo intravascular ultra-
sonography to detect atherosclerotic changes and 
plaque burden in the lumen and walls of the coro-
nary arteries, the coexistence of non-obstructive 
CAD in patients with “isolated” CSF could not be 
established with certainty. Third, we did not per-
form analyses based on the number of leads with 
fQRS on the ECG, which might have decreased the 
predictive value of narrow fQRS for the presence 
of the CSF phenomenon. The final limitation of 
the present study was the lack of follow-up of the 
patients in terms of major adverse cardiac events, 
including mortality due to hemodynamically sig-
nificant arrhythmic events, that could have helped 
to determine the significance of a narrow fQRS as 
a novel risk stratification tool.
Conclusions
The presence of a narrow fQRS on the admis-
sion ECG is associated with the occurrence of CSF 
confirmed by coronary angiography. Moreover, it is 
significantly related with the extent and severity of 
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CSF. The fQRS, which reflects impaired ventricu-
lar depolarization due to heterogeneous electrical 
activation of ischemic and/or injured ventricular 
myocardium, is a simple, inexpensive, and readily 
available noninvasive ECG parameter that could 
serve as a new potential indicator of myocardial 
damage in patients with CSF. Further studies with 
larger patient groups are needed to clarify the exact 
pathophysiological mechanisms and the relation 
between a narrow fQRS and CSF.
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